Search

Simon Lab members attended the research retreat. Alejandra and Emily presented "Pharmacological stabilization of the retromer complex results in the reduction of α-synuclein accumulation and in the control of α-synuclein clearance pathways" and joined in conversations about the latest research at...

"Researchers Halt Progression in Parkinson's Disease Mouse Model" discussed in BIDMC press release Jacqueline Mitchell reports on the Simon Lab's contributions to a deeper understanding of the mechanisms underlying Parkinson's Disease and the best novel targets to investigate potential treatments...

On April 3, 2025, SPARK NS announced the 2025 awardees. Each investigator will be provided up to $2 million over 2 years plus access to expertise and education to support translation of potential Parkinson's treatments from the lab into clinical trials. We are thrilled to be included in this cohort...

The Simon Lab article highlighting the role of USP30 in a Parkinson's disease mouse model is published in Nature Communications